Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

被引:266
|
作者
Ferslew, Brian C. [1 ,2 ]
Xie, Guoxiang [3 ]
Johnston, Curtis K. [1 ]
Su, Mingming [3 ]
Stewart, Paul W. [4 ]
Jia, Wei [3 ]
Brouwer, Kim L. R. [1 ]
Barritt, A. Sidney [5 ]
机构
[1] Univ N Carolina, UNC Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA
[2] Theravance Biopharma US Inc, Clin Pharmacol & Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[3] Univ Hawaii, Ctr Canc, Metabol Shared Resource, Honolulu, HI 96813 USA
[4] Univ N Carolina, UNC Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, UNC Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
Nonalcoholic steatohepatitis; Bile acids; Bile acid metabolome; Enterohepatic recirculation; FATTY LIVER-DISEASE; URSODEOXYCHOLIC ACID; ACTIVATION; APOPTOSIS; RECEPTOR; CANCER; INJURY; METAANALYSIS; HOMEOSTASIS; POPULATION;
D O I
10.1007/s10620-015-3776-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The prevalence of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) is increasing at an alarming rate. The role of bile acids in the development and progression of NAFLD to NASH and cirrhosis is poorly understood. This study aimed to quantify the bile acid metabolome in healthy subjects and patients with non-cirrhotic NASH under fasting conditions and after a standardized meal. Liquid chromatography tandem mass spectroscopy was used to quantify 30 serum and 16 urinary bile acids from 15 healthy volunteers and 7 patients with biopsy-confirmed NASH. Bile acid concentrations were measured at two fasting and four post-prandial time points following a high-fat meal to induce gallbladder contraction and bile acid reabsorption from the intestine. Patients with NASH had significantly higher total serum bile acid concentrations than healthy subjects under fasting conditions (2.2- to 2.4-fold increase in NASH; NASH 2595-3549 A mu M and healthy 1171-1458 A mu M) and at all post-prandial time points (1.7- to 2.2-fold increase in NASH; NASH 4444-5898 A mu M and healthy 2634-2829 A mu M). These changes were driven by increased taurine- and glycine-conjugated primary and secondary bile acids. Patients with NASH exhibited greater variability in their fasting and post-prandial bile acid profile. Results indicate that patients with NASH have higher fasting and post-prandial exposure to bile acids, including the more hydrophobic and cytotoxic secondary species. Increased bile acid exposure may be involved in liver injury and the pathogenesis of NAFLD and NASH.
引用
收藏
页码:3318 / 3328
页数:11
相关论文
共 50 条
  • [21] Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis
    Yamada, Kazutoshi
    Mizukoshi, Eishiro
    Sunagozaka, Hajime
    Arai, Kuniaki
    Yamashita, Tatsuya
    Takeshita, Yumie
    Misu, Hirofumi
    Takamura, Toshinari
    Kitamura, Seiko
    Zen, Yoh
    Nakanuma, Yasuni
    Honda, Masao
    Kaneko, Shuichi
    [J]. LIVER INTERNATIONAL, 2015, 35 (02) : 582 - 590
  • [22] Molecular mechanism of altered ezetimibe disposition in nonalcoholic steatohepatitis
    Hardwick, Rhiannon N.
    Fisher, Craig D.
    Street, Stephanie M.
    Canet, Mark J.
    Cherrington, Nathan J.
    [J]. DRUG METABOLISM REVIEWS, 2011, 43 : 78 - 78
  • [23] Mechanistic Basis of Altered Morphine Disposition in Nonalcoholic Steatohepatitis
    Dzierlenga, Anika L.
    Clarke, John D.
    Hargraves, Tiffanie L.
    Ainslie, Garrett R.
    Vanderah, Todd W.
    Paine, Mary F.
    Cherrington, Nathan J.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 352 (03): : 462 - 470
  • [24] Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis
    Hardwick, Rhiannon N.
    Fisher, Craig D.
    Street, Stephanie M.
    Canet, Mark J.
    Cherrington, Nathan J.
    [J]. DRUG METABOLISM AND DISPOSITION, 2012, 40 (03) : 450 - 460
  • [25] Nonalcoholic Steatohepatitis Is Associated with Altered Hepatic MicroRNA Expression
    Cheung, Onpan
    Puri, Puneet
    Eicken, Christoph
    Contos, Melissa J.
    Mirshahi, Faridoddin
    Maher, James W.
    Kellum, John M.
    Min, Haeki
    Luketic, Velimir A.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2008, 48 (06) : 1810 - 1820
  • [26] Obeticholic acid for the treatment of nonalcoholic steatohepatitis
    Shah, Raj A.
    Kowdley, Kris, V
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 311 - 321
  • [27] Ursodeoxicolic acid in the treatment of nonalcoholic steatohepatitis
    Bagci, S
    Uygun, A
    Kadayifci, A
    Bektas, A
    Ates, Y
    Erdil, A
    Karaeren, N
    Dagalp, K
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 195 - 195
  • [28] Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis
    Yoshiaki Sugiyama
    Kenta Yamamoto
    Takashi Honda
    Asuka Kato
    Hisanori Muto
    Shinya Yokoyama
    Takanori Ito
    Norihiro Imai
    Yoji Ishizu
    Masanao Nakamura
    Tomomi Asano
    Atsushi Enomoto
    Kei Zaitsu
    Masatoshi Ishigami
    Mitsuhiro Fujishiro
    Hiroki Kawashima
    [J]. Hepatology International, 2023, 17 : 1378 - 1392
  • [29] Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis
    María Eugenia Inzaugarat
    Nazarena Eugenia Ferreyra Solari
    Luis Ariel Billordo
    Raquel Abecasis
    Adrian C. Gadano
    Alejandra Claudia Cherñavsky
    [J]. Journal of Clinical Immunology, 2011, 31 : 1120 - 1130
  • [30] Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis
    Sugiyama, Yoshiaki
    Yamamoto, Kenta
    Honda, Takashi
    Kato, Asuka
    Muto, Hisanori
    Yokoyama, Shinya
    Ito, Takanori
    Imai, Norihiro
    Ishizu, Yoji
    Nakamura, Masanao
    Asano, Tomomi
    Enomoto, Atsushi
    Zaitsu, Kei
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    Kawashima, Hiroki
    [J]. HEPATOLOGY INTERNATIONAL, 2023, 17 (06) : 1378 - 1392